Home › Core › ISCC-IDs › 28CrZV9hjLLUV

View ISCC-ID

Core Data

28CrZV9hjLLUV
ISCC-ID - digital asset identifier
CCeiQ1Bh2JcEd-CTWe83t9ncZg2-CDhNpChXUiN3d-CR5xdDZx4Hze4
ISCC-CODE - digital asset descriptor
2QTa5N4aeSrCB2MLoPdPF4AsTjstJgcLTnd
PUBLIC-KEY or WALLET-ADDRESS of DECLARING PARTY
0
Number of times updated

Seed Metadata (Immutable)

in vivo efficacy of a humansimulated regimen of ceftaroline combined with nxl104 against extendedspectrum lactamase esblproducin

Ledger Reference

coblo
Source Ledger/Blockchain
316674
N-th ISCC Decleration on source ledger
6fd8ba9af6c6ea75efefbd07c6403d358f28c2c1ab622e0b9c260d422099d169
Hash of block that includes the ISCC-DECLARATION
71f51cd1a01157055f328c809742101699703d5f77eaf01ee07e624501a0b98d
Hash of transaction that includes the ISCC-DECLERATION
0
Output index that includes ISCC-DECLERATION (UTXO based chains)

Mutable Metadata

[{"data": {"name": "In Vivo Efficacy of a Human-Simulated Regimen of Ceftaroline Combined with NXL104 against Extended-Spectrum-\u00a0-Lactamase (ESBL)-Producing and Non-ESBL-Producing Enterobacteriaceae", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "D. E. Wiskirchen", "@type": "Person"}, {"name": "J. L. Crandon", "@type": "Person"}, {"name": "G. H. Furtado", "@type": "Person"}, {"name": "G. Williams", "@type": "Person"}, {"name": "D. P. Nicolau", "@type": "Person"}], "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "https://aac.asm.org/content/aac/55/7/3220.full.pdf", "encodingFormat": "application/pdf"}], "publisher": {"name": "American Society for Microbiology", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.1128/aac.00024-11", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCeiQ1Bh2JcEd-CTWe83t9ncZg2-CDhNpChXUiN3d-CR5xdDZx4Hze4", "propertyID": "ISCC"}], "datePublished": "2011-04-25"}, "schema": "schema.org", "mediatype": "application/ld+json"}]
Close